On February 15th, 2022, the European Commission (EC) declared CBDepot’s Novel Food application NF 2021/2283 for isolated trans-Cannabidiol as valid. This sets the number of CBDepot’s valid Novel Food applications with EC and FSA to four.
Gerresheimer AG, a leading provider of healthcare & beauty solutions and drug delivery systems for pharma, biotech and cosmetics, is further accelerating its profitable growth. The strategic program of formula G is realigning the business with megatrends such as healthcare, sustainability and biotech. Three years in implementing formula G to foster sustainable profitable growth, Gerresheimer has beaten its revenue guidance in 2021. Last year the company generated EUR 1,497m in core business revenues, achieving a strong organic growth of 7.6%. Core business adjusted EBITDA increased to EUR 324m on a currency-adjusted basis meeting the forecast range.
Owen Mumford Pharmaceutical Services, a division of Owen Mumford Ltd. announces that its UniSafe® 1mL safety device for pre-filled syringes
Investment increases production in Wertheim by 150 million vials and creates 70 new jobs Next step on the way to
Start your year right and keep your goals on track with NSF’s training and education. NSF's pharma training and education
NETZSCH-Gerätebau GmbH is writing 60 years of company history! Together with you, we would like to duly celebrate our company
UGA Biopharma GmbH (UGA), the leading-edge contract development and research organization for biologics and biosimilars, has entered a partnership with
Important agreement with significant sales and revenue potential Development of a new pump to deliver a leading rare disease drug,
Ueli Utzinger is to become Gerresheimer AG’s new Group Senior Director Communication & Marketing as of December 1, 2021. He
Novozymes and Novo Nordisk Pharmatech are joining forces to develop best-in-class technical enzymes to support production processes in the biopharmaceutical industry.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.